BIB Holdings — ProShares Ultra Nasdaq Biotechnology
All 258 reported holdings of ProShares Ultra Nasdaq Biotechnology (BIB) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| ProShares GENIUS Money Market ETF | 6.80% | $5.01M |
| Gilead Sciences, Inc. | 4.66% | $3.43M |
| Vertex Pharmaceuticals, Inc. | 4.65% | $3.43M |
| Amgen, Inc. | 4.48% | $3.30M |
| Regeneron Pharmaceuticals, Inc. | 3.21% | $2.36M |
| Repurchase Agreement | 3.14% | $2.31M |
| Alnylam Pharmaceuticals, Inc. | 2.01% | $1.48M |
| Revolution Medicines, Inc. | 1.57% | $1.15M |
| Biogen, Inc. | 1.44% | $1.06M |
| Illumina, Inc. | 1.25% | $921.21K |
| United Therapeutics Corp. | 1.22% | $902.05K |
| Royalty Pharma plc | 1.20% | $883.07K |
| Argenx SE | 1.19% | $877.79K |
| Insmed, Inc. | 1.16% | $851.86K |
| Roivant Sciences Ltd. | 1.08% | $793.54K |
| Incyte Corp. | 0.97% | $711.91K |
| Viatris, Inc. | 0.94% | $692.11K |
| Moderna, Inc. | 0.94% | $688.97K |
| Guardant Health, Inc. | 0.85% | $629.00K |
| Invesco Govt And Agcy Lex | 0.81% | $598.02K |
| Neurocrine Biosciences, Inc. | 0.80% | $587.61K |
| Jazz Pharmaceuticals plc | 0.73% | $538.01K |
| Ascendis Pharma A/S | 0.69% | $510.07K |
| Summit Therapeutics, Inc. | 0.68% | $502.77K |
| Exelixis, Inc. | 0.66% | $484.61K |
| Bridgebio Pharma, Inc. | 0.64% | $474.89K |
| Medpace Holdings, Inc. | 0.64% | $469.91K |
| Ionis Pharmaceuticals, Inc. | 0.63% | $467.34K |
| Axsome Therapeutics, Inc. | 0.60% | $443.17K |
| Madrigal Pharmaceuticals, Inc. | 0.57% | $421.19K |
| BioMarin Pharmaceutical, Inc. | 0.55% | $407.33K |
| BioNTech SE | 0.55% | $404.24K |
| Arrowhead Pharmaceuticals, Inc. | 0.55% | $403.42K |
| Sanofi SA | 0.54% | $395.08K |
| Praxis Precision Medicines, Inc. | 0.49% | $360.12K |
| Cytokinetics, Inc. | 0.47% | $349.49K |
| BeOne Medicines Ltd. | 0.46% | $340.03K |
| Krystal Biotech, Inc. | 0.45% | $333.75K |
| Tempus AI, Inc. | 0.44% | $324.22K |
| Abivax SA | 0.41% | $301.20K |
| Nuvalent, Inc. | 0.41% | $298.60K |
| Halozyme Therapeutics, Inc. | 0.39% | $290.38K |
| ImmunityBio, Inc. | 0.39% | $285.82K |
| Vaxcyte, Inc. | 0.37% | $273.50K |
| Alkermes plc | 0.35% | $260.02K |
| Immunovant, Inc. | 0.34% | $250.52K |
| Kymera Therapeutics, Inc. | 0.33% | $245.64K |
| Protagonist Therapeutics, Inc. | 0.32% | $235.06K |
| Mirum Pharmaceuticals, Inc. | 0.31% | $226.45K |
| PTC Therapeutics, Inc. | 0.31% | $226.13K |
| Rhythm Pharmaceuticals, Inc. | 0.30% | $223.10K |
| Spyre Therapeutics, Inc. | 0.29% | $213.52K |
| Cogent Biosciences, Inc. | 0.28% | $209.83K |
| CRISPR Therapeutics AG | 0.27% | $199.44K |
| CG oncology, Inc. | 0.26% | $194.53K |
| Scholar Rock Holding Corp. | 0.25% | $186.01K |
| Centessa Pharmaceuticals plc | 0.24% | $175.86K |
| Caris Life Sciences, Inc. | 0.24% | $174.41K |
| Ligand Pharmaceuticals, Inc. | 0.23% | $170.72K |
| Xenon Pharmaceuticals, Inc. | 0.23% | $168.24K |
| Apogee Therapeutics, Inc. | 0.23% | $166.58K |
| Indivior Pharmaceuticals, Inc. | 0.23% | $166.56K |
| Travere Therapeutics, Inc. | 0.22% | $160.84K |
| Amneal Pharmaceuticals, Inc. | 0.21% | $153.19K |
| Twist Bioscience Corp. | 0.21% | $151.53K |
| Erasca, Inc. | 0.20% | $146.94K |
| Newamsterdam Pharma Co. NV | 0.19% | $143.21K |
| Crinetics Pharmaceuticals, Inc. | 0.19% | $137.65K |
| ACADIA Pharmaceuticals, Inc. | 0.19% | $136.52K |
| Veracyte, Inc. | 0.18% | $136.15K |
| Edgewise Therapeutics, Inc. | 0.18% | $135.48K |
| Beam Therapeutics, Inc. | 0.17% | $124.05K |
| Denali Therapeutics, Inc. | 0.17% | $123.36K |
| 10X Genomics, Inc. | 0.17% | $123.16K |
| Dyne Therapeutics, Inc. | 0.16% | $117.66K |
| Structure Therapeutics, Inc. | 0.15% | $113.30K |
| Tango Therapeutics, Inc. | 0.15% | $109.42K |
| Oruka Therapeutics, Inc. | 0.14% | $104.71K |
| GRAIL, Inc. | 0.14% | $103.15K |
| Alumis, Inc. | 0.14% | $100.96K |
| Arcutis Biotherapeutics, Inc. | 0.13% | $98.44K |
| Disc Medicine, Inc. | 0.13% | $98.16K |
| Supernus Pharmaceuticals, Inc. | 0.13% | $97.90K |
| Ideaya Biosciences, Inc. | 0.13% | $95.66K |
| Vera Therapeutics, Inc. | 0.13% | $93.63K |
| Tarsus Pharmaceuticals, Inc. | 0.13% | $93.44K |
| Relay Therapeutics, Inc. | 0.13% | $92.81K |
| Mineralys Therapeutics, Inc. | 0.13% | $92.14K |
| Definium Therapeutics, Inc. | 0.12% | $89.14K |
| Enliven Therapeutics, Inc. | 0.12% | $86.90K |
| Adaptive Biotechnologies Corp. | 0.12% | $86.23K |
| Ultragenyx Pharmaceutical, Inc. | 0.12% | $85.49K |
| Legend Biotech Corp. | 0.12% | $84.79K |
| Kodiak Sciences, Inc. | 0.11% | $82.78K |
| BioCryst Pharmaceuticals, Inc. | 0.11% | $82.60K |
| Kiniksa Pharmaceuticals International plc | 0.11% | $82.15K |
| Aurinia Pharmaceuticals, Inc. | 0.10% | $75.33K |
| Ocular Therapeutix, Inc. | 0.10% | $72.52K |
| Novocure Ltd. | 0.10% | $71.72K |
| Pharvaris NV | 0.10% | $71.39K |
| Sionna Therapeutics, Inc. | 0.10% | $70.70K |
| ADMA Biologics, Inc. | 0.10% | $70.26K |
| Rapport Therapeutics, Inc. | 0.09% | $69.68K |
| Zymeworks, Inc. | 0.09% | $69.51K |
| Recursion Pharmaceuticals, Inc. | 0.09% | $69.28K |
| Sarepta Therapeutics, Inc. | 0.09% | $69.25K |
| AbCellera Biologics, Inc. | 0.09% | $69.16K |
| Harmony Biosciences Holdings, Inc. | 0.09% | $67.60K |
| Nurix Therapeutics, Inc. | 0.09% | $67.52K |
| Trevi Therapeutics, Inc. | 0.09% | $67.05K |
| Novavax, Inc. | 0.09% | $66.07K |
| Tyra Biosciences, Inc. | 0.09% | $65.95K |
| uniQure NV | 0.09% | $65.76K |
| Stoke Therapeutics, Inc. | 0.09% | $65.25K |
| ANI Pharmaceuticals, Inc. | 0.09% | $65.16K |
| Syndax Pharmaceuticals, Inc. | 0.09% | $63.88K |
| Agios Pharmaceuticals, Inc. | 0.09% | $63.68K |
| Genmab A/S | 0.09% | $62.64K |
| Vericel Corp. | 0.08% | $62.49K |
| Iovance Biotherapeutics, Inc. | 0.08% | $62.45K |
| Intellia Therapeutics, Inc. | 0.08% | $61.47K |
| AtaiBeckley, Inc. | 0.08% | $60.83K |
| Taysha Gene Therapies, Inc. | 0.08% | $59.45K |
| Innoviva, Inc. | 0.08% | $58.69K |
| Amylyx Pharmaceuticals, Inc. | 0.08% | $58.25K |
| AnaptysBio, Inc. | 0.08% | $56.95K |
| Precigen, Inc. | 0.08% | $56.77K |
| Inhibrx Biosciences, Inc. | 0.08% | $55.85K |
| Monte Rosa Therapeutics, Inc. | 0.08% | $55.54K |
| Vir Biotechnology, Inc. | 0.08% | $55.43K |
| GH Research plc | 0.07% | $55.03K |
| Ardelyx, Inc. | 0.07% | $54.76K |
| Fortrea Holdings, Inc. | 0.07% | $53.17K |
| MBX Biosciences, Inc. | 0.07% | $52.18K |
| Bicara Therapeutics, Inc. | 0.07% | $50.96K |
| KalVista Pharmaceuticals, Inc. | 0.07% | $50.25K |
| Septerna, Inc. | 0.07% | $50.04K |
| UroGen Pharma Ltd. | 0.07% | $48.66K |
| Harrow, Inc. | 0.07% | $48.24K |
| Maze Therapeutics, Inc. | 0.06% | $47.05K |
| Immunocore Holdings plc | 0.06% | $46.83K |
| ArriVent Biopharma, Inc. | 0.06% | $46.22K |
| WaVe Life Sciences Ltd. | 0.06% | $45.80K |
| Compass Pathways plc | 0.06% | $45.54K |
| Personalis, Inc. | 0.06% | $44.11K |
| MannKind Corp. | 0.06% | $42.94K |
| EyePoint, Inc. | 0.06% | $41.58K |
| Alvotech SA | 0.06% | $41.03K |
| Collegium Pharmaceutical, Inc. | 0.05% | $39.39K |
| Savara, Inc. | 0.05% | $39.12K |
| Olema Pharmaceuticals, Inc. | 0.05% | $39.07K |
| Corvus Pharmaceuticals, Inc. | 0.05% | $37.90K |
| Xeris Biopharma Holdings, Inc. | 0.05% | $37.79K |
| Absci Corp. | 0.05% | $37.54K |
| Zenas Biopharma, Inc. | 0.05% | $36.49K |
| Cullinan Therapeutics, Inc. | 0.05% | $35.92K |
| Grifols SA | 0.05% | $35.40K |
| Pacira BioSciences, Inc. | 0.05% | $34.71K |
| ARS Pharmaceuticals, Inc. | 0.04% | $33.16K |
| Kura Oncology, Inc. | 0.04% | $32.82K |
| Janux Therapeutics, Inc. | 0.04% | $32.84K |
| Sana Biotechnology, Inc. | 0.04% | $32.50K |
| Arbutus Biopharma Corp. | 0.04% | $32.42K |
| Xencor, Inc. | 0.04% | $32.21K |
| MeiraGTx Holdings plc | 0.04% | $31.68K |
| Amphastar Pharmaceuticals, Inc. | 0.04% | $31.61K |
| ORIC Pharmaceuticals, Inc. | 0.04% | $31.36K |
| Eton Pharmaceuticals, Inc. | 0.04% | $30.21K |
| Theravance Biopharma, Inc. | 0.04% | $30.11K |
| Mesoblast Ltd. | 0.04% | $29.78K |
| Geron Corp. | 0.04% | $29.50K |
| Annexon, Inc. | 0.04% | $28.99K |
| Omeros Corp. | 0.04% | $28.95K |
| Phathom Pharmaceuticals, Inc. | 0.04% | $27.93K |
| BioAge Labs, Inc. | 0.04% | $27.73K |
| Esperion Therapeutics, Inc. | 0.04% | $27.66K |
| Replimune Group, Inc. | 0.04% | $26.53K |
| Maravai LifeSciences Holdings, Inc. | 0.04% | $25.97K |
| CorMedix, Inc. | 0.03% | $24.57K |
| Zevra Therapeutics, Inc. | 0.03% | $24.14K |
| Prime Medicine, Inc. | 0.03% | $23.69K |
| Phibro Animal Health Corp. | 0.03% | $23.49K |
| Castle Biosciences, Inc. | 0.03% | $23.19K |
| Vor BioPharma, Inc. | 0.03% | $22.99K |
| CytomX Therapeutics, Inc. | 0.03% | $22.55K |
| Zai Lab Ltd. | 0.03% | $22.45K |
| Candel Therapeutics, Inc. | 0.03% | $22.47K |
| Design Therapeutics, Inc. | 0.03% | $22.06K |
| Tectonic Therapeutic, Inc. | 0.03% | $21.60K |
| Ironwood Pharmaceuticals, Inc. | 0.03% | $21.52K |
| Arvinas, Inc. | 0.03% | $21.22K |
| Solid Biosciences, Inc. | 0.03% | $21.14K |
| Rigel Pharmaceuticals, Inc. | 0.03% | $20.49K |
| Aclaris Therapeutics, Inc. | 0.03% | $20.29K |
| Prothena Corp. plc | 0.03% | $20.25K |
| 4D Molecular Therapeutics, Inc. | 0.03% | $18.68K |
| Aquestive Therapeutics, Inc. | 0.02% | $18.13K |
| Allogene Therapeutics, Inc. | 0.02% | $18.03K |
| Kyverna Therapeutics, Inc. | 0.02% | $17.99K |
| Aura Biosciences, Inc. | 0.02% | $17.55K |
| Fulcrum Therapeutics, Inc. | 0.02% | $17.05K |
| Upstream Bio, Inc. | 0.02% | $16.69K |
| Pacific Biosciences of California, Inc. | 0.02% | $16.63K |
| Kamada Ltd. | 0.02% | $16.67K |
| First Tracks Biotherapeutics, Inc. | 0.02% | $16.33K |
| Neurogene, Inc. | 0.02% | $16.18K |
| C4 Therapeutics, Inc. | 0.02% | $15.77K |
| Evolus, Inc. | 0.02% | $15.72K |
| Lakefront Biotherapeutics NV | 0.02% | $15.54K |
| Contineum Therapeutics, Inc. | 0.02% | $15.16K |
| OmniAb, Inc. | 0.02% | $14.37K |
| Enanta Pharmaceuticals, Inc. | 0.02% | $14.11K |
| Altimmune, Inc. | 0.02% | $14.12K |
| Vanda Pharmaceuticals, Inc. | 0.02% | $14.10K |
| Larimar Therapeutics, Inc. | 0.02% | $13.97K |
| Lexeo Therapeutics, Inc. | 0.02% | $13.86K |
| Autolus Therapeutics plc | 0.02% | $13.86K |
| Immuneering Corp. | 0.02% | $13.77K |
| Lyell Immunopharma, Inc. | 0.02% | $13.64K |
| Atea Pharmaceuticals, Inc. | 0.02% | $13.49K |
| Puma Biotechnology, Inc. | 0.02% | $13.47K |
| Cabaletta Bio, Inc. | 0.02% | $13.45K |
| REGENXBIO, Inc. | 0.02% | $13.13K |
| Keros Therapeutics, Inc. | 0.02% | $12.66K |
| Editas Medicine, Inc. | 0.02% | $12.49K |
| SIGA Technologies, Inc. | 0.02% | $12.38K |
| Rocket Pharmaceuticals, Inc. | 0.02% | $12.32K |
| Silence Therapeutics plc | 0.02% | $11.98K |
| Invivyd, Inc. | 0.02% | $11.68K |
| Neumora Therapeutics, Inc. | 0.02% | $11.43K |
| Alpha Teknova, Inc. | 0.01% | $10.70K |
| Anavex Life Sciences Corp. | 0.01% | $10.38K |
| Entrada Therapeutics, Inc. | 0.01% | $10.01K |
| AC Immune SA | 0.01% | $9.90K |
| Codexis, Inc. | 0.01% | $9.25K |
| Foghorn Therapeutics, Inc. | 0.01% | $9.27K |
| Humacyte, Inc. | 0.01% | $9.28K |
| LENZ Therapeutics, Inc. | 0.01% | $9.01K |
| Coherus Oncology, Inc. | 0.01% | $8.78K |
| Quantum-Si, Inc. | 0.01% | $8.60K |
| Sagimet Biosciences, Inc. | 0.01% | $8.36K |
| Voyager Therapeutics, Inc. | 0.01% | $8.43K |
| Arcturus Therapeutics Holdings, Inc. | 0.01% | $8.33K |
| Orchestra BioMed Holdings, Inc. | 0.01% | $8.17K |
| Caribou Biosciences, Inc. | 0.01% | $8.15K |
| Bicycle Therapeutics plc | 0.01% | $8.02K |
| NovaBridge Biosciences | 0.01% | $7.64K |
| Lifecore Biomedical, Inc. | 0.01% | $6.96K |
| Tenaya Therapeutics, Inc. | 0.01% | $6.96K |
| Jyong Biotech Ltd. | 0.01% | $6.03K |
| Black Diamond Therapeutics, Inc. | 0.01% | $4.67K |
| Pyxis Oncology, Inc. | 0.01% | $4.15K |
| PepGen, Inc. | 0.01% | $3.81K |
| Rani Therapeutics Holdings, Inc. | 0.00% | $3.43K |
| Aardvark Therapeutics, Inc. | 0.00% | $3.30K |
| Gossamer Bio, Inc. | 0.00% | $1.98K |
| Third Harmonic Bio, Inc. | 0.00% | $0 |
| Cartesian Therapeutics, Inc. | 0.00% | $0 |